228 related articles for article (PubMed ID: 28081230)
1. Characteristics of HIV-Infected Children at Enrollment into Care and at Antiretroviral Therapy Initiation in Central Africa.
Adedimeji A; Edmonds A; Hoover D; Shi Q; Sinayobye JD; Nduwimana M; Lelo P; Nash D; Anastos K; Yotebieng M
PLoS One; 2017; 12(1):e0169871. PubMed ID: 28081230
[TBL] [Abstract][Full Text] [Related]
2. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
3. Trends in demographic and clinical characteristics and initiation of antiretroviral therapy among adult patients enrolling in HIV care in the Central Africa International epidemiology Database to Evaluate AIDS (CA-IeDEA) 2004 to 2018.
Adedimeji AA; Hoover DR; Shi Q; Kim HY; Brazier E; Ross J; Murenzi G; Twizere C; Lelo P; Nsonde D; Ajeh R; Dzudie A; Nash D; Yotebieng M; Anastos K;
J Int AIDS Soc; 2021 Jun; 24(6):e25672. PubMed ID: 34152663
[TBL] [Abstract][Full Text] [Related]
4. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
Desmonde S; Tanser F; Vreeman R; Takassi E; Edmonds A; Lumbiganon P; Pinto J; Malateste K; McGowan C; Kariminia A; Yotebieng M; Dicko F; Yiannoutsos C; Mubiana-Mbewe M; Wools-Kaloustian K; Davies MA; Leroy V;
PLoS Med; 2018 May; 15(5):e1002565. PubMed ID: 29727458
[TBL] [Abstract][Full Text] [Related]
5. Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.
Brazier E; Tymejczyk O; Wools-Kaloustian K; Jiamsakul A; Torres MTL; Lee JS; Abuogi L; Khol V; Mejía Cordero F; Althoff KN; Law MG; Nash D;
PLoS Med; 2024 Mar; 21(3):e1004367. PubMed ID: 38498589
[TBL] [Abstract][Full Text] [Related]
6. Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort.
Jesson J; Koumakpaï S; Diagne NR; Amorissani-Folquet M; Kouéta F; Aka A; Lawson-Evi K; Dicko F; Kouakou K; Pety T; Renner L; Eboua T; Coffie PA; Desmonde S; Leroy V;
Pediatr Infect Dis J; 2015 Jul; 34(7):e159-68. PubMed ID: 25955835
[TBL] [Abstract][Full Text] [Related]
7. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
Lancet HIV; 2019 Feb; 6(2):e105-e115. PubMed ID: 30723008
[TBL] [Abstract][Full Text] [Related]
8. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
[TBL] [Abstract][Full Text] [Related]
9. HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
Tymejczyk O; Brazier E; Yiannoutsos C; Wools-Kaloustian K; Althoff K; Crabtree-Ramírez B; Van Nguyen K; Zaniewski E; Dabis F; Sinayobye JD; Anderegg N; Ford N; Wikramanayake R; Nash D;
PLoS Med; 2018 Mar; 15(3):e1002534. PubMed ID: 29570723
[TBL] [Abstract][Full Text] [Related]
10. Growth in the first 5 years after antiretroviral therapy initiation among HIV-infected children in the IeDEA West African Pediatric Cohort.
Jesson J; Ephoevi-Ga A; Desmonde S; Ake-Assi MH; D'Almeida M; Sy HS; Malateste K; Amorissani-Folquet M; Dicko F; Kouadio K; Renner L; Leroy V;
Trop Med Int Health; 2019 Jun; 24(6):775-785. PubMed ID: 30945378
[TBL] [Abstract][Full Text] [Related]
11. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
[TBL] [Abstract][Full Text] [Related]
12. Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis.
Tymejczyk O; Brazier E; Yiannoutsos CT; Vinikoor M; van Lettow M; Nalugoda F; Urassa M; Sinayobye JD; Rebeiro PF; Wools-Kaloustian K; Davies MA; Zaniewski E; Anderegg N; Liu G; Ford N; Nash D;
PLoS Med; 2019 Jun; 16(6):e1002822. PubMed ID: 31181056
[TBL] [Abstract][Full Text] [Related]
13. Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study.
Iyun V; Technau KG; Vinikoor M; Yotebieng M; Vreeman R; Abuogi L; Desmonde S; Edmonds A; Amorissani-Folquet M; Davies MA;
Lancet HIV; 2021 Jun; 8(6):e353-e362. PubMed ID: 33932330
[TBL] [Abstract][Full Text] [Related]
14. Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.
Lahuerta M; Wu Y; Hoffman S; Elul B; Kulkarni SG; Remien RH; Nuwagaba-Biribonwoha H; El-Sadr W; Nash D; ;
Clin Infect Dis; 2014 Feb; 58(3):432-41. PubMed ID: 24198226
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
[TBL] [Abstract][Full Text] [Related]
16. High retention among HIV-infected children in Rwanda during scale-up and decentralization of HIV care and treatment programs, 2004 to 2010.
Tene G; Lahuerta M; Teasdale C; Mugisha V; Kayonde L; Muhayimpundu R; Nyemazi JP; Vandebriel G; Nsanzimana S; Sahabo R; Twyman P; Abrams EJ
Pediatr Infect Dis J; 2013 Aug; 32(8):e341-7. PubMed ID: 23407098
[TBL] [Abstract][Full Text] [Related]
17. Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia.
Mody A; Sikazwe I; Czaicki NL; Wa Mwanza M; Savory T; Sikombe K; Beres LK; Somwe P; Roy M; Pry JM; Padian N; Bolton-Moore C; Holmes CB; Geng EH
PLoS Med; 2018 Jun; 15(6):e1002574. PubMed ID: 29870531
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of HIV-infected children seen in Western Kenya.
Nyandiko WM; Mwangi A; Ayaya SO; Nabakwe EC; Tenge CN; Gisore PM; Vreeman RC
East Afr Med J; 2009 Aug; 86(8):364-73. PubMed ID: 20575310
[TBL] [Abstract][Full Text] [Related]
19. Impact of WHO guidelines on trends in HIV testing and ART initiation among children living with HIV in Zambia.
Munthali T; Michelo C; Mee P; Moyo C; Kashoka A; Liswaniso L; Chiboma I; Todd J
AIDS Res Ther; 2020 May; 17(1):18. PubMed ID: 32408890
[TBL] [Abstract][Full Text] [Related]
20. Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis.
van Dijk JH; Sutcliffe CG; Munsanje B; Hamangaba F; Thuma PE; Moss WJ
BMC Infect Dis; 2009 Oct; 9():169. PubMed ID: 19835604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
